In Vitro Lung Model Market Overview:
The lung in Vitro Models Market is expected to reach USD 427.4 Million by 2023 from an estimated USD 190.5 Million in 2018, at a CAGR of 17.5%. Factors such as growing focus on developing alternatives for animal testing models, technological advancements, and the development of new 3D in vitro models are expected to drive market growth.
The global lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018 at a CAGR of 17.5%. This market is fragmented in nature with a large number of regional and national players. In 2017, Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland) were the top players in the lung in vitro models market and accounted for more than ~80% of the overall market share.
ATCC is an established provider of cell lines and primary cells in the global market. ATCC develops high-quality products, standards, and services to support scientific research and breakthroughs. It has a strong market presence due to its broad portfolio of lung cell lines and primary cell models of normal and diseased lungs. ATCC has a direct sales force in the US and maintains a global network of authorized distributors and partners to reach the scientific community in more than 150 countries. Given its strong portfolio of lung cell lines and primary cells, the company holds the leading position in the global lung in vitro models market.
Request For Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=78042820
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the in vitro lung model market and estimate the size of other dependent submarkets. Various secondary sources such as the American Lung Association, National Center for Biotechnology Information, National Centre for Advancing Translational Sciences, European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM), European Lung Foundation, Annual Reports, Presentations, Press Releases, Journals, Paid Databases, have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78042820
Segmentation:
Lung In Vitro Models Market, By Type
2D Models
3D Models
In-house 3D Models
Commercialized 3D Models
Lung In Vitro Models Market, By Application
Applications of 2D Models
Drug Discovery and Toxicology
3D Model Development
Basic Research
Applications of 3D Models
Drug Discovery and Toxicology
Physiological Research
Stem Cell Research and Regenerative Medicine
Fore More Detail:
https://www.marketsandmarkets.com/Market-Reports/lung-in-vitro-model-market-78042820.html
Key Players:
The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
